Cas:73839-20-0 tert-Butyl 6-Hydroxyhexanoate manufacturer & supplier

We serve Chemical Name:tert-Butyl 6-Hydroxyhexanoate CAS:73839-20-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-Butyl 6-Hydroxyhexanoate

Chemical Name:tert-Butyl 6-Hydroxyhexanoate
CAS.NO:73839-20-0
Synonyms:6-Hydroxy-hexanoic Acid 1,1-Dimethylethyl Ester;tert-Butyl6-hydroxyhexanoate
Molecular Formula:C10H20O3
Molecular Weight:188.26400
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:246.8ºC at 760 mmHg
Density:0.967g/cm3
Index of Refraction:1.443
PSA:46.53000
Exact Mass:188.14100
LogP:1.88080

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 6-Hydroxy-hexanoic Acid 1,1-Dimethylethyl Ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-Butyl6-hydroxyhexanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-Butyl6-hydroxyhexanoate Use and application,6-Hydroxy-hexanoic Acid 1,1-Dimethylethyl Ester technical grade,usp/ep/jp grade.


Related News: The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. tert-Butyl 6-Hydroxyhexanoate manufacturer As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials. tert-Butyl 6-Hydroxyhexanoate supplier The company’s product reserves are rich, with more than one hundred varieties in various categories from intermediates to APIs. At present, the grays and anti-hepatitis C series intermediates are steadily advancing, which will ensure future growth. tert-Butyl 6-Hydroxyhexanoate vendor The drug substance is an active product that has completed the synthetic route, and the intermediate is a product in one place in the synthetic route. tert-Butyl 6-Hydroxyhexanoate factory As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.